Considerable interest in the biobehavioural pathways linking stress and cancer as well as the identification of modifiable risk factors has increased research examining psychological adjustment, biological responses, and cancer outcomes. Although most of this work has focused on how stress affects processes such as immune surveillance that govern survival of tumors, less attention has been directed at how stress contributes to somatic mutation and genomic instability. Progress in this area may be facilitated by considering how stress affects events that modulate development and accumulation of somatic mutations in addition to those affecting survival of tumor cells. It is possible that a sharper focus on other relevant biological processes such as increases in DNA damage, alterations in DNA repair, and inhibition of apoptosis, may explain more of the variance in disease outcomes.
No takes yet. Share an insight, caveat, or question.
Forlenza et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: